These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Hematopoietic growth factors. Current status of therapy]. Hiddemann W Internist (Berl); 1994 Apr; 35(4):395-400. PubMed ID: 7515381 [No Abstract] [Full Text] [Related]
9. Management of fever in patients with cancer and treatment-induced neutropenia. Pizzo PA N Engl J Med; 1993 May; 328(18):1323-32. PubMed ID: 8469254 [No Abstract] [Full Text] [Related]
10. Clinical uses of hematopoietic growth hormones in HIV-related illnesses. Mitsuyasu RT AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940 [No Abstract] [Full Text] [Related]
11. In vitro biological activities of the haemopoietic growth factors: implications for their clinical use. Testa NG Acta Haematol; 1991; 86(3):122-7. PubMed ID: 1785226 [TBL] [Abstract][Full Text] [Related]
12. Clinical use of recombinant hematopoietic colony-stimulating factors. Shepro DS; Sullivan R Adv Intern Med; 1991; 36():329-62. PubMed ID: 2024585 [No Abstract] [Full Text] [Related]
13. Haemopoietic growth factor and dose intensity in high-grade and intermediate-grade lymphoma. Pettengell R; Crowther D Ann Oncol; 1994; 5 Suppl 2():133-41. PubMed ID: 7911317 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic use of hematopoietic growth factors. Costa JJ J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493 [No Abstract] [Full Text] [Related]
15. Cytokines and hematopoietins: physiology, pathophysiology, and potential as therapeutic agents. Mertelsmann R; Rosenthal FM; Lindemann A; Herrmann F Recent Results Cancer Res; 1991; 121():121-40. PubMed ID: 1857854 [No Abstract] [Full Text] [Related]
16. Regulatory issues involved in hematopoietic growth factor approval. Zoon KC; Cohen RB; Gerrard T Semin Oncol; 1992 Aug; 19(4):432-40. PubMed ID: 1380733 [No Abstract] [Full Text] [Related]